Tatsuta Clinic

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Depression1 trial
• Schizophrenia1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed2 trials

Lead sponsor

• Boehringer Ingelheim2 trials

Closed trials

• Completed

  Clinical Trial of Iclepertin Effect on Cognition and Functional Capacity in Schizophrenia (CONNEX-2)

  NCT04846881· Phase 3· Boehringer Ingelheim· Source

• Completed

  A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression

  NCT04521478· Phase 2· Boehringer Ingelheim· Source